SCHEMBL7863476

SCHEMBL7863476

CC(=O)c1cc(C(=O)O)cc(N(c2ccccc2)S(C)(=O)=O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.43
TSHR P16473 1/20 0.43
BACE1 P56817 4/20 0.41
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39
GAA P10253 1/20 0.38
CTSD P07339 3/20 0.38
BACE2 Q9Y5Z0 3/20 0.38
NSD2 O96028 1/20 0.37
ESR1 P03372 1/20 0.37
POLB P06746 1/20 0.37
APEX1 P27695 1/20 0.37
RECQL P46063 1/20 0.37
ESR2 Q92731 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 2/20 0.36
SMN1; SMN2 Q16637 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7857856 0.86 BACE1 (0.45) KMT2ATSHRBACE1PTGS2GAA
SCHEMBL5928621 0.85 TPMT (0.47) KMT2ABACE1GAACTSDBACE2
SCHEMBL13229343 0.84 TSHR (0.45) KMT2ATSHRBACE1PTGS2GAA
SCHEMBL5720761 0.84 RECQL (0.39) KMT2ATSHRBACE1CTSDBACE2
SCHEMBL5720746 0.84 ALDH1A1 (0.40) KMT2ABACE1PTGS2GAACTSD
SCHEMBL5720737 0.84 DHODH (0.46) BACE1CTSDBACE2
SCHEMBL5720785 0.83 ALDH1A1 (0.47) KMT2ATSHRBACE1CTSDBACE2
SCHEMBL5720783 0.81 TAS2R14 (0.39) KMT2ATSHRBACE1GAACTSD
SCHEMBL894882 0.80 TSHR (0.46) KMT2ATSHRNSD2ESR1POLB
SCHEMBL5720739 0.80 CTSD (0.48) KMT2ATSHRBACE1CTSDBACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7476764-B2 Phenylcarboxyamides as beta-secretase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2009-01-13 US disclosed
US-7476764-B2 Phenylcarboxyamides as beta-secretase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2009-01-13 US disclosed
US-20070032470-A1 Novel phenylcarboxyamides as beta-secretase inhibitors BRISTOL-MYERS SQUIBB COMPANY 2007-02-08 US disclosed
US-20070032470-A1 Novel phenylcarboxyamides as beta-secretase inhibitors BRISTOL-MYERS SQUIBB COMPANY 2007-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032470-A1 Novel phenylcarboxyamides as beta-secretase inhibitors BACE1, APP, BACE2 KMT2A 2775/4885TSHR 4580/4885BACE1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.